The inhibitory effect of 163 was regulated by the inactivation of the NF-κB, MAPK, and TLR4/MyD88 signaling pathways, indicating that 163 is potential anti-inflammatory candidate for the treatment of neurodegenerative diseases [72] (Figure 8). This evidence concerns the gene MYD88 and neurodegenerative disease.